Tengjun Biotechnology Corp. Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from Q1 2021 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
Tengjun Biotechnology Corp. quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q1 2021 to Q2 2023.
  • Tengjun Biotechnology Corp. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending June 30, 2023 was -$2.46M, a 163% decline year-over-year.
  • Tengjun Biotechnology Corp. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending June 30, 2023 was $5.04M, a 35.9% increase year-over-year.
  • Tengjun Biotechnology Corp. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2022 was $11.1M.
  • Tengjun Biotechnology Corp. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was -$784K, a 3.26% decline from 2020.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $5.04M -$2.46M -$6.33M -163% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-15
Q1 2023 $11.4M $484K +$274K +131% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $11.1M $4.01M +$4.28M Oct 1, 2022 Dec 31, 2022 10-K 2023-04-17
Q3 2022 $6.81M $3M +$3.11M Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $3.7M $3.88M +$4.12M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-15
Q1 2022 -$414K $210K +$369K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$784K -$271K Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 -$111K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$242K Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-09-16
Q1 2021 -$160K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.